Federal Register / Vol. 79, No. 116 / Tuesday, June 17, 2014 / Notices 34537 

the publication stage each year. Annual 

follow-up reviews will be conducted 

with all innovations that have been in 

the Innovations Exchange for at least 

one full year. With an expected total of 

825 innovations in the Exchange by the 

end of the current approval period, and 

an additional 225 to be added over the 

course of the next 3-year approval 

period (75 per year), an average of 800 

reviews will be conducted annually and 

will require about 15 minutes to 

complete. The number of profiles 

undergoing annual review will increase 

annually from 825 in the first year, to 

900 in the second year, and 975 in the 

third year. The average annualized 

number of annual follow-up reviews is 

projected to be 800 as it is anticipated 

that approximately 100 profiles will be 

archived over three years. Archived 

profiles are excluded from annual 

review. The total annualized burden is 

estimated to be 347 hours. 

EXHIBIT 1—ESTIMATED ANNUALIZED BURDEN HOURS

Form name Number of 

respondents 

Number of 

responses per 

respondent 

Hours per 

response 

Total burden 

hours 

Email submission ............................................................................................. 8 1 30/60 4 

Health care innovator interview ....................................................................... 84 1 75/60 105 

Innovator review and approval of written profile ............................................. 75 1 30/60 38 

Annual follow-up reviews ................................................................................. 800 1 15/60 200 

Total .......................................................................................................... 967 ........................ ........................ 347 

Exhibit 2 shows the estimated 

annualized cost burden associated with 

the respondents’ time to participate in 

this project. The total annualized cost 

burden is estimated to be $21,220. 

EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN

Form name Number of 

respondents 

Total burden 

hours 

Average 

hourly wage 

rate * 

Total cost 

burden 

Email submission ............................................................................................. 8 4 $61.15 $245 

Health care innovator interview ....................................................................... 84 105 61.15 6,421 

Innovator review and approval of written profile ............................................. 75 38 61.15 2,324 

Annual follow-up reviews ................................................................................. 800 200 61.15 12,230 

Total .......................................................................................................... 967 347 ........................ 21,220 

* Average hourly wage rate for health care innovators is based upon statistics from the Bureau of Labor Statistics, U.S. Department of Labor, 

Occupational Employment and Wages, May 2012 (http://www.bls.gov/oes/current/oes290000.htm), and was calculated as an average of the 

mean hourly wage rate for Family and General Practitioners and the mean hourly wage for all occupations in the major group, ‘‘Healthcare Practitioners and Technical Occupations’’. 

Request for Comments 

In accordance with the Paperwork 

Reduction Act, comments on AHRQ’s 

information collection are requested 

with regard to any of the following: (a) 

Whether the proposed collection of 

information is necessary for the proper 

performance of AHRQ health care 

research and health care information 

dissemination functions, including 

whether the information will have 

practical utility; (b) the accuracy of 

AHRQ’s estimate of burden (including 

hours and costs) of the proposed 

collection(s) of information; (c) ways to 

enhance the quality, utility, and clarity 

of the information to be collected; and 

(d) ways to minimize the burden of the 

collection of information upon the 

respondents, including the use of 

automated collection techniques or 

other forms of information technology. 

Comments submitted in response to 

this notice will be summarized and 

included in the Agency’s subsequent 

request for OMB approval of the 

proposed information collection. All 

comments will become a matter of 

public record. 

Dated: May 29, 2014. 

Richard Kronick, 

AHRQ Director. 

[FR Doc. 2014–14082 Filed 6–16–14; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

National Advisory Council for 

Healthcare Research and Quality: 

Request for Nominations for Public 

Members 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), HHS. 

ACTION: Notice of request for 

nominations for public members. 

SUMMARY: 42 U.S.C. 299c establishes a 

National Advisory Council for 

Healthcare Research and Quality (the 

Council). The Council is to advise the 

Secretary of HHS (Secretary) and the 

Director of the Agency for Healthcare 

Research and Quality (AHRQ) on 

matters related to activities of the 

Agency to improve the quality, safety, 

efficiency, and effectiveness of health 

care for all Americans. 

Seven current members’ terms will 

expire in November 2014. To fill these 

positions, we are seeking individuals 

who are distinguished: (1) In the 

conduct of research, demonstration 

projects, and evaluations with respect to 

health care; (2) in the fields of health 

care quality research or health care 

improvement; (3) in the practice of 

medicine; (4) in other health 

professions; (5) in representing the 

private health care sector (including 

health plans, providers, and purchasers) 

or administrators of health care delivery 

systems; (6) in the fields of health care 


tkelley on DSK3SPTVN1PROD with NOTICES
34538 Federal Register / Vol. 79, No. 116 / Tuesday, June 17, 2014 / Notices 

economics, information systems, law, 

ethics, business, or public policy; and, 

(7) in representing the interests of 

patients and consumers of health care. 

42 U.S.C. 299c(c)(2). Individuals are 

particularly sought with experience and 

success in activities specified in the 

summary above. 

DATES: Nominations should be received 

on or before 60 days after date of 

publication. 

ADDRESSES: Nominations should be sent 

to Ms. Karen Brooks, AHRQ, 540 

Gaither Road, Room 3006, Rockville, 

Maryland 20850. Nominations may also 

be emailed to Karen.Brooks@

ahrq.hhs.gov. 

FOR FURTHER INFORMATION CONTACT: Ms. 

Karen Brooks, AHRQ, at (301) 427– 

1801. 

SUPPLEMENTARY INFORMATION: 42 U.S.C. 

299e provides that the Secretary shall 

appoint to the National Advisory 

Council for Healthcare Research and 

Quality twenty one appropriately 

qualified individuals. At least seventeen 

members shall be representatives of the 

public and at least one member shall be 

a specialist in the rural aspects of one 

or more of the professions or fields 

listed in the above summary. In 

addition, the Secretary designates, as ex 

officio members, representatives from 

other Federal agencies, principally 

agencies that conduct or support health 

care research, as well as Federal officials 

the Secretary may consider appropriate. 

42 U.S.C. 299c(c)(3). The Council meets 

in the Washington, DC, metropolitan 

area, generally in Rockville, Maryland, 

approximately three times a year to 

provide broad guidance to the Secretary 

and AHRQ’s Director on the direction of 

and programs undertaken by AHRQ. 

Seven individuals will be selected 

presently by the Secretary to serve on 

the Council beginning with the meeting 

in the spring of 2015. Members 

generally serve 3-year terms. 

Appointments are staggered to permit 

an orderly rotation of membership. 

Interested persons may nominate one 

or more qualified persons for 

membership on the Council. Selfnominations are accepted. Nominations 

shall include: (1) A copy of the 

nominee’s resume or curriculum vitae; 

and (2) a statement that the nominee is 

willing to serve as a member of the 

Council. Selected candidates will be 

asked to provide detailed information 

concerning their financial interests, 

consultant positions and research grants 

and contracts, to permit evaluation of 

possible sources of conflict of interest. 

Please note that once you are 

nominated, AHRQ may consider your 

nomination for future positions on the 

Council. Federally registered lobbyists 

are not permitted to serve on this 

advisory board pursuant to the 

Presidential Memorandum entitled 

‘‘Lobbyists on Agency Boards and 

Commissions’’ dated June 10, 2010, and 

the Office of Management and Budget’s 

‘‘Final Guidance on Appointment of 

Lobbyists to Federal Boards and 

Commissions,’’ 76 Fed. Reg. 61756 

(October 5, 2011). 

The Department seeks a broad 

geographic representation. In addition, 

AHRQ conducts and supports research 

concerning priority populations, which 

include: low-income groups; minority 

groups; women; children; the elderly; 

and individuals with special health care 

needs, including individuals with 

disabilities and individuals who need 

chronic care or end-of-life health care. 

See 42 U.S.C. 299(c). Nominations of 

persons with expertise in health care for 

these priority populations are 

encouraged. 

Dated: May 29 2014. 

Richard Kronick, 

AHRQ Director. 

[FR Doc. 2014–14081 Filed 6–16–14; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Scientific Information Request on 

Diagnosis and Treatment of Myalgic 

Encephalomyelitis/Chronic Fatigue 

Syndrome (ME/CFS) 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), HHS. 

ACTION: Request for scientific 

information submissions. 

SUMMARY: The Agency for Healthcare 

Research and Quality (AHRQ) is seeking 

scientific information submissions from 

the public. Scientific information is 

being solicited to inform our review of 

Diagnosis and Treatment of Myalgic 

Encephalomyelitis/Chronic Fatigue 

Syndrome (ME/CFS), which is currently 

being conducted by the Evidence-based 

Practice Centers for the AHRQ Effective 

Health Care Program. Access to 

published and unpublished pertinent 

scientific information will improve the 

quality of this review. AHRQ is 

conducting this systematic review 

pursuant to Section 1013 of the 

Medicare Prescription Drug, 

Improvement, and Modernization Act of 

2003, Public Law 108–173, and Section 

902(a) of the Public Health Service Act, 

42 U.S.C. 299a(a). 

DATES: Submission Deadline on or 

before July 17, 2014. 

ADDRESSES: Online submissions: http:// 

effectivehealthcare.AHRQ.gov/

index.cfm/submit-scientificinformation-packets/. Please select the 

study for which you are submitting 

information from the list to upload your 

documents. Email submissions: SIPS@

epc-src.org. 

Print Submissions 

Mailing Address: Portland VA Research 

Foundation, Scientific Resource 

Center, ATTN: Scientific Information 

Packet Coordinator, PO Box 69539, 

Portland, OR 97239. 

Shipping Address (FedEx, UPS, etc.): 

Portland VA Research Foundation, 

Scientific Resource Center, ATTN: 

Scientific Information Packet 

Coordinator, 3710 SW U.S. Veterans 

Hospital Road, Mail Code: R&D 71, 

Portland, OR 97239. 

FOR FURTHER INFORMATION CONTACT: 

Ryan McKenna, Telephone: 503–220– 

8262 ext. 58653 or Email: SIPS@

epcsrc.org. 

SUPPLEMENTARY INFORMATION: The 

Agency for Healthcare Research and 

Quality has commissioned the Effective 

Health Care (EHC) Program Evidencebased Practice Centers to complete a 

review of the evidence for Diagnosis and 

Treatment of Myalgic 

Encephalomyelitis/Chronic Fatigue 

Syndrome (ME/CFS). 

The EHC Program is dedicated to 

identifying as many studies as possible 

that are relevant to the questions for 

each of its reviews. In order to do so, we 

are supplementing the usual manual 

and electronic database searches of the 

literature by requesting information 

from the public (e.g., details of studies 

conducted). We are looking for studies 

that report on Diagnosis and Treatment 

of Myalgic Encephalomyelitis/Chronic 

Fatigue Syndrome (ME/CFS), including 

those that describe adverse events. The 

entire research protocol, including the 

key questions, is also available online 

at: http://effectivehealthcare.AHRQ.gov/ 

search-for-guides-reviews-and-reports/

?pageaction=displayproduct&productID

=1906#8766. 

This notice is to notify the public that 

the EHC program would find the 

following information on Diagnosis and 

Treatment of Myalgic 

Encephalomyelitis/Chronic Fatigue 

Syndrome (ME/CFS). 

• A list of completed studies your 

company has sponsored for this 

indication. In the list, indicate whether 

results are available on 


tkelley on DSK3SPTVN1PROD with NOTICES